 | • レポートコード：MRC2301H007 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、238ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の市場調査によると、2021年の3,555.14百万ドルであった世界の尿失禁機器市場規模は、2022年には3,837.24百万ドルへ達し、2027年までに年平均8.11%成長して5,676.80百万ドルへ拡大すると予想されています。本調査資料では、尿失禁機器の世界市場を調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（人工尿道括約筋、電気刺激装置、パッド・大人用おむつ、尿道スリング、その他）分析、失禁種類別（機能性尿失禁、溢流性尿失禁、腹圧性尿失禁、切迫性尿失禁）分析、カテゴリー別（外部尿失禁機器、内部尿失禁機器）分析、エンドユーザー別（診療所、在宅医療設備、病院）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目を掲載しています。また、当書ではAeroflow Urology、Atlantic Therapeutics、B. Braun Melsungen AG、Baxter、BD、Boston Scientific Corporation、Carewell、Coloplast A/S、Comfort Medical、ConvaTec Group PLC、Flexicare Medical Limited、HDIS、Hollister Incorporated、Home Care Delivered、Karl Storz GmbH & Co. KG、Lily Bird、LiveAnewなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の尿失禁機器市場規模：製品別 - 人工尿道括約筋の市場規模 - 電気刺激装置の市場規模 - パッド・大人用おむつの市場規模 - 尿道スリングの市場規模 - その他尿失禁機器の市場規模 ・世界の尿失禁機器市場規模：失禁種類別 - 機能性尿失禁における市場規模 - 溢流性尿失禁における市場規模 - 腹圧性尿失禁の市場規模 - 切迫性尿失禁の市場規模 ・世界の尿失禁機器市場規模：カテゴリー別 - 外部尿失禁機器の市場規模 - 内部尿失禁機器の市場規模 ・世界の尿失禁機器市場規模：エンドユーザー別 - 診療所における市場規模 - 在宅医療設備における市場規模 - 病院における市場規模 ・世界の尿失禁機器市場規模：地域別 - 南北アメリカの尿失禁機器市場規模 アメリカの尿失禁機器市場規模 カナダの尿失禁機器市場規模 ブラジルの尿失禁機器市場規模 ... - アジア太平洋の尿失禁機器市場規模 日本の尿失禁機器市場規模 中国の尿失禁機器市場規模 インドの尿失禁機器市場規模 韓国の尿失禁機器市場規模 台湾の尿失禁機器市場規模 ... - ヨーロッパ/中東/アフリカの尿失禁機器市場規模 イギリスの尿失禁機器市場規模 ドイツの尿失禁機器市場規模 フランスの尿失禁機器市場規模 ロシアの尿失禁機器市場規模 ... - その他地域の尿失禁機器市場規模 ・競争状況 ・企業情報 |
The Global Urinary Incontinence Device Market size was estimated at USD 3,555.14 million in 2021 and expected to reach USD 3,837.24 million in 2022, and is projected to grow at a CAGR 8.11% to reach USD 5,676.80 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Urinary Incontinence Device to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Artificial Urinary Sphincters, Electrical Stimulation Devices, Pads & Adult Diapers, Urethral Slings, Urinary Catheters, and Vaginal Slings. The Vaginal Slings is further studied across Advanced Vaginal Slings and Conventional Vaginal Slings.
Based on Incontinence Type, the market was studied across Functional Incontinence, Overflow Incontinence, Stress Incontinence, and Urge Continence.
Based on Categary, the market was studied across External Urinary Incontinence Devices and Internal Urinary Incontinence Devices.
Based on End User, the market was studied across Clinics, Home care settings, Home care settings, and Hospitals.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Urinary Incontinence Device market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Urinary Incontinence Device Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Urinary Incontinence Device Market, including Aeroflow Urology, Atlantic Therapeutics, B. Braun Melsungen AG, Baxter, BD, Boston Scientific Corporation, Carewell, Coloplast A/S, Comfort Medical, ConvaTec Group PLC, Flexicare Medical Limited, HDIS, Hollister Incorporated, Home Care Delivered, Karl Storz GmbH & Co. KG, Lily Bird, LiveAnew, Medline At Home, Medtronic, Men’s Liberty, Nexwear, Nipro Corporation, Northshore Care Supply, PROMEDON GmbH, Speax, Teleflex Incorporated, TotalDry, Tranquility Products, Veeda, and Zephyr Surgical Implants.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Urinary Incontinence Device Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Urinary Incontinence Device Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Urinary Incontinence Device Market?
4. What is the competitive strategic window for opportunities in the Global Urinary Incontinence Device Market?
5. What are the technology trends and regulatory frameworks in the Global Urinary Incontinence Device Market?
6. What is the market share of the leading vendors in the Global Urinary Incontinence Device Market?
7. What modes and strategic moves are considered suitable for entering the Global Urinary Incontinence Device Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Geriatric population and increasing prevalence of urinary incontinence devices
5.1.1.2. Demand for minimally invasive surgery and product development
5.1.1.3. Increased product availability and FDA approvals thriving commercialization
5.1.2. Restraints
5.1.2.1. Increase in the unaware incontinent patient population
5.1.3. Opportunities
5.1.3.1. Increasing technological advancements in urinary incontinence devices
5.1.3.2. Growing demand for Urethral Slings
5.1.4. Challenges
5.1.4.1. Limited awareness and social stigma associated with the disease
5.1.4.2. Unknown risks and complications from the procedures
5.2. Cumulative Impact of COVID-19
6. Urinary Incontinence Device Market, by Product
6.1. Introduction
6.2. Artificial Urinary Sphincters
6.3. Electrical Stimulation Devices
6.4. Pads & Adult Diapers
6.5. Urethral Slings
6.6. Urinary Catheters
6.7. Vaginal Slings
6.8.1. Advanced Vaginal Slings
6.8.2. Conventional Vaginal Slings
7. Urinary Incontinence Device Market, by Incontinence Type
7.1. Introduction
7.2. Functional Incontinence
7.3. Overflow Incontinence
7.4. Stress Incontinence
7.5. Urge Continence
8. Urinary Incontinence Device Market, by Categary
8.1. Introduction
8.2. External Urinary Incontinence Devices
8.3. Internal Urinary Incontinence Devices
9. Urinary Incontinence Device Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Home care settings
9.4. Home care settings
9.5. Hospitals
10. Americas Urinary Incontinence Device Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Urinary Incontinence Device Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Urinary Incontinence Device Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Aeroflow Urology
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Atlantic Therapeutics
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. B. Braun Melsungen AG
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Baxter
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. BD
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Boston Scientific Corporation
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Carewell
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Coloplast A/S
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Comfort Medical
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. ConvaTec Group PLC
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Flexicare Medical Limited
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. HDIS
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Hollister Incorporated
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Home Care Delivered
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Karl Storz GmbH & Co. KG
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Lily Bird
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. LiveAnew
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Medline At Home
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Medtronic
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Men’s Liberty
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Nexwear
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
14.22. Nipro Corporation
14.22.1. Business Overview
14.22.2. Key Executives
14.22.3. Product & Services
14.23. Northshore Care Supply
14.23.1. Business Overview
14.23.2. Key Executives
14.23.3. Product & Services
14.24. PROMEDON GmbH
14.24.1. Business Overview
14.24.2. Key Executives
14.24.3. Product & Services
14.25. Speax
14.25.1. Business Overview
14.25.2. Key Executives
14.25.3. Product & Services
14.26. Teleflex Incorporated
14.26.1. Business Overview
14.26.2. Key Executives
14.26.3. Product & Services
14.27. TotalDry
14.27.1. Business Overview
14.27.2. Key Executives
14.27.3. Product & Services
14.28. Tranquility Products
14.28.1. Business Overview
14.28.2. Key Executives
14.28.3. Product & Services
14.29. Veeda
14.29.1. Business Overview
14.29.2. Key Executives
14.29.3. Product & Services
14.30. Zephyr Surgical Implants
14.30.1. Business Overview
14.30.2. Key Executives
14.30.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing